Product Information

CEPHALEXIN 125 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0727 per ML under NDC 67877054488. Its NADAC has been published 377 times since Sep 4, 2019.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CEPHALEXIN 125 MG/5 ML SUSP

Cephalexin
$0.0727per ML
High Outlier

Strength

125 mg/5mL

NDC

67877054488

Classification

Generic

Dosage Form

FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CEPHALEXIN

Approval Type

Generic (ANDA)

FDA Application

ANDA210221

FDA Approved

3/26/2019

TE Code

AB

On Market Since

3/28/2019

Pharmacological Classes

Price Statistics

The NADAC for CEPHALEXIN 125 MG/5 ML SUSP has been published 377 times since Sep 4, 2019, and over the history we have for it it has declined 40.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0727 per ML
All-time high$0.1226 (Sep 11, 2019)
All-time low$0.0444 (May 22, 2024)
52-week high$0.0820
52-week low$0.0637
Median price$0.0741
Average price$0.0732
Largest weekly change+72.8% (Feb 22, 2023)
Weeks tracked377
Tracking sinceSep 4, 2019

Price History

1W

-4.3%

1M

-2.9%

3M

+0.2%

6M

-3.5%

1Y

-8.0%

3Y

-4.9%

5Y

-6.5%

All

-40.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEPHALEXIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 125 MG/5 ML SUSP, manufactured by Ascend Laboratories, LLC, is $0.0727 per ML (NDC 67877054488), effective Nov 18, 2026.

How has the price of CEPHALEXIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEPHALEXIN 125 MG/5 ML SUSP has declined 40.7%. It has been tracked across 377 weekly CMS publications since Sep 4, 2019.

What are the highest and lowest recorded NADAC prices for CEPHALEXIN 125 MG/5 ML SUSP?

Since Sep 4, 2019, the NADAC for CEPHALEXIN 125 MG/5 ML SUSP has ranged from a low of $0.0444 (May 22, 2024) to a high of $0.1226 (Sep 11, 2019), with a median of $0.0741 per ML.

Are there cheaper alternatives to CEPHALEXIN 125 MG/5 ML SUSP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEPHALEXIN 125 MG/5 ML SUSP, is $0.0423 per ML — about 42% below CEPHALEXIN 125 MG/5 ML SUSP.

Who manufactures CEPHALEXIN 125 MG/5 ML SUSP?

CEPHALEXIN 125 MG/5 ML SUSP (NDC 67877054488) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.